Sign in

You're signed outSign in or to get full access.

Marc Duber

Director at FVCBankcorp
Board

About Marc N. Duber

Marc N. Duber, age 66, has served as an independent director of FVCBankcorp, Inc. since October 2022. He is Executive Vice President and Chief Operating Officer of The Bernstein Companies, a Washington, D.C.–based real estate firm where he began his career in 1980, with expertise spanning strategic acquisitions, ground-up development, hotel and commercial property management. He is an alumnus of American University and served as Chairman of its Board of Trustees from 2019 to 2023; he has also held governance roles at Washington Hospital Center and MedStar Health, including chairing the philanthropy committee for the MedStar Georgetown University Hospital Capital Campaign .

Past Roles

OrganizationRoleTenureCommittees/Impact
The Bernstein CompaniesExecutive Vice President & Chief Operating Officer1980–present Focus on strategic acquisitions, ground-up developments, investments, and managing hotel and commercial properties

External Roles

OrganizationRoleTenureCommittees/Impact
American UniversityChairman, Board of Trustees2019–2023 Led board governance at AU
Washington Hospital CenterFormer Chairman of the BoardNot disclosed Oversight of hospital governance
MedStar Health, Inc.Former Board MemberNot disclosed Chaired philanthropy committee for MedStar Georgetown University Hospital Capital Campaign

Board Governance

  • Independence: The Board determined all directors other than the CEO/Chair (David W. Pijor) and President (Patricia A. Ferrick) are independent under Nasdaq Rule 5605(a)(2); Duber is independent .
  • Committee assignments: 2024-2025 standing committees and membership—Audit (Laughlin, Schwartz–Chair, Simmonds), Compensation (Testa–Chair, Wills, Krishnan), Governance & Nominating (Gunn–Chair, Testa, Wiltse). Duber is not listed on these standing committees .
  • Attendance and engagement: The Board held 12 regular meetings in 2024; each director attended at least 75% of aggregate Board and committee meetings; independent directors met once in executive session .
  • Board leadership: CEO and Chairman roles are combined; lead independent director (L. Burwell Gunn) oversees executive sessions, consistent with Nasdaq requirements .

Fixed Compensation

ItemAmount (USD)
Fees Earned or Paid in Cash (2024)$62,400
Stock Awards (2024)$0
All Other Compensation (2024)$0

Director fee schedule (policy-level):

ComponentAmount (USD)
Annual Board retainer (non-employee directors)$45,000
Board meeting fee (per meeting)$1,000
Director Loan Committee (per meeting)$600
Audit Committee (per meeting)$300; Chair $400
Asset-Liability Management Committee (per meeting)$200
Technology Committee (per meeting)$200
Compensation Committee annual retainer$1,000; Chair $2,000

Performance Compensation

Component2024 GrantsUnvested at 12/31/2024Notes
RSUs$0 0 shares No director equity granted in 2024
Options$0 0 shares (all directors’ outstanding options listed; Duber has none) No option awards outstanding for Duber

No director performance metrics (TSR, revenue, ESG) are tied to director compensation; directors did not receive equity compensation in 2024 .

Other Directorships & Interlocks

CategoryDetails
Current public company boardsNone disclosed
Nonprofit/academic boardsAmerican University (Chairman, 2019–2023); Washington Hospital Center (former Chairman); MedStar Health (former Board member; philanthropy committee chair)
Potential interlocks/conflictsReal estate executive background may intersect with bank customers in real estate/hospitality; the Board considered ordinary-course banking relationships in independence determinations

Expertise & Qualifications

  • Four decades in real estate development, acquisitions, and property management, including hotel assets—valuable for credit and real estate risk oversight at a regional bank .
  • Chair experience at major nonprofit boards (American University; Washington Hospital Center) and philanthropy leadership at MedStar Health, indicating governance and stakeholder engagement capabilities .

Equity Ownership

MetricValue
Common stock beneficially owned (as of 4/4/2025)3,668 shares
Percentage of class<1%
Options included in beneficial ownershipNone
Unvested director RSUs at 12/31/20240 shares
  • Anti-hedging/pledging: Company policy prohibits directors and officers from hedging, short sales, trading on margin, and pledging Company stock as collateral .
  • Shares outstanding (context for % ownership): 18,406,216 at record date (April 4, 2025) .

Insider Trades and Section 16 Compliance

IndicatorStatus
Section 16(a) filings (2024)No failures noted for directors/officers except one late Form 4 for Director Philip R. Wills; no issues cited for Duber

Governance Assessment

  • Strengths: Independent director; solid governance pedigree; anti-hedging/pledging policy supports alignment; no Section 16 compliance issues noted for Duber .
  • Weaknesses: 2024 director compensation was entirely cash with no equity grants; Duber holds a small personal stake (3,668 shares, <1%), which may temper alignment versus equity-heavy structures .
  • Potential conflicts: The Bank engages in ordinary-course transactions with insiders/related parties; maximum insider/related loans reached $53.4 million in 2024 (≈22.7% of shareholders’ equity), though terms were market-based and none were problem loans—Board independence review explicitly considered such relationships; Duber’s real estate executive role warrants monitoring for any related-party exposure or customer overlaps (none specifically disclosed) .
  • Board structure risk: Combined CEO/Chair model can constrain independent oversight; mitigated by Lead Independent Director and executive sessions, but remains a governance consideration for investors .

Overall signal: Duber is an experienced, independent director with strong external governance credentials. Alignment relies on policy-based safeguards rather than equity grants; investors may prefer increased director equity participation to strengthen pay-for-performance linkage, while monitoring any real estate-linked related-party exposures under the Bank’s ordinary-course lending framework .